Skip to main content

1 Result(s)

within M R Stefanovski Remove this filter

and

  1. No Access

    Article

    The CD37-targeted antibody–drug conjugate IMGN529 is highly active against human CLL and in a novel CD37 transgenic murine leukemia model

    Therapeutic regimens for chronic lymphocytic leukemia (CLL) have increasingly utilized monoclonal antibodies since the chimeric anti-CD20 antibody rituximab was introduced. Despite improved clinical outcomes, ...

    K A Beckwith, F W Frissora, M R Stefanovski, W H Towns, C Cheney, X Mo… in Leukemia (2014)